(Q44454449)

3 December 2017

Treatment of status epilepticus: a survey of neurologists (English)

1 reference

3 December 2017

1 reference

1

0 references

Lawrence James Hirsch

series ordinal

2

0 references

Stephan A. Mayer

series ordinal

3

0 references

publication date

1 July 2003

1 reference

Journal of the Neurological Sciences

3 December 2017

1 reference

3 December 2017

211

1 reference

3 December 2017

1-2

1 reference

3 December 2017

37-41

1 reference

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Refractory status epilepticus: frequency, risk factors, and impact on outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Management approaches to prolonged seizures and status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Refractory status epilepticus in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Use of midazolam in the treatment of refractory status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Intravenous valproate is well tolerated in unstable patients with status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Role of propofol in refractory status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Nonconvulsive status epilepticus in the emergency room.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Complex partial status epilepticus accompanied by serious morbidity and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

The EEG and prognosis in status epilepticus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900036-4

10.1016/S0022-510X(03)00036-4

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12767495